Stemtech Corporation, a leader in stem cell nutrition based in Naples, Florida, has announced that its core products are now ready for shipment. This milestone follows the company”s efforts to address various challenges related to supply delivery and manufacturing.
In a statement, Charles S. Arnold, Chairman and CEO of Stemtech Corporation, explained that the company faced delays in fulfilling customer orders due to supply issues stemming from tariffs and capital constraints affecting some internationally sourced raw materials. He noted that increased market awareness of the benefits of stem cell nutrition has significantly amplified demand for their products.
Arnold expressed optimism about moving beyond the supply challenges that had previously led to backorders in the United States. He emphasized that the company is now in a position to fulfill orders efficiently. In particular, Stemtech”s largest market, Mexico, is currently ramping up production, with inventory soon available for shipping to customers. Additionally, products are already en route to Canada and Ecuador.
